17 studies found for:    Tropical Spastic Paraparesis
Show Display Options
RSS Create an RSS feed from your search for:
Tropical Spastic Paraparesis
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
Condition: Tropical Spastic Paraparesis
Intervention:
2 Unknown  Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Tamibarotene
3 Suspended Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Condition: HTLV-1
Intervention: Drug: Hu MiK-Beta-1
4 Completed Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)
Conditions: HTLV-I Infection;   Spinal Cord Disease;   Tropical Spastic Paraparesis
Intervention: Drug: Recombinant human interferon beta-1a
5 Completed A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis
Condition: HTLV-I
Intervention:
6 Completed Zidovudine Plus Lamivudine in HTLV-I-Associated Myelopathy: a Randomised Trial
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Zidovudine/lamivudine
7 Recruiting Evaluation of Patients With HAM/TSP
Conditions: HTLV-I Infection;   Tropical Spastic Paraparesis
Intervention:
8 Completed Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Condition: HTLV I Associated Myelopathy
Intervention: Drug: ciclosporin
9 Recruiting Raltegravir for HAM/TSP
Conditions: HAM/TSP;   HTLV-1
Intervention: Drug: Raltegravir
10 Enrolling by invitation Urological Physical Therapy in HTLV-1 With Urinary Symptoms
Conditions: Tropical Spastic Paraparesis;   HTLV-1
Intervention: Procedure: Urological physical therapy
11 Unknown  Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases
Conditions: HTLV-1;   Tropical Spastic Paraparesis;   Immune System Diseases;   Physical Disability;   Pentoxifylline
Interventions: Drug: Pentoxifylline;   Drug: Placebo
12 Completed Assessment of Patients With Multiple Sclerosis (MS)
Conditions: Herpesviridae Infection;   HTLV-I Infection;   Multiple Sclerosis;   Tropical Spastic Paraparesis;   Vasculitis
Intervention:
13 Unknown  Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)
Condition: Paraparesis Spastic Tropical
Interventions: Drug: Valproic acid;   Drug: costicosteroids;   Drug: valproid acid plus corticosteroids
14 Terminated The HAM Infliximab Study
Condition: HTLV-I-associated Myelopathy
Intervention: Drug: Infliximab
15 Not yet recruiting Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1
Condition: HTLV-I Infections
Intervention:
16 Enrolling by invitation Evaluation of the MP Diagnostics HTLV Blot 2.4
Conditions: HTLV-I Infections;   HTLV-II Infections;   Human T-lymphotropic Virus 1;   Human T-lymphotropic Virus 2;   HTLV I Associated T Cell Leukemia Lymphoma;   HTLV I Associated Myelopathies
Intervention: Other: CDPHL Algorithm
17 Terminated Safety and Efficiency Study of Valproic Acid In HAM/TSP
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Valproic Acid

Indicates status has not been verified in more than two years